Condition
Unresectable Metastatic Colorectal Cancer clinical trials and research
As of November 12, 2026, Find a Trial lists 4 Unresectable Metastatic Colorectal Cancer clinical trials that are recruiting, at sites in 3 countries (most in Belgium (3), United States (3), France (2)). By phase: Phase 1 (2), Phase 1/2 (1), Phase 3 (1). Every study is explained in plain English. Data from ClinicalTrials.gov and NIH RePORTER, updated November 12, 2026.
- 4Clinical trials
- 3Countries
Newest Unresectable Metastatic Colorectal Cancer clinical trials
| Study | Phase | Where | Status | Registered |
|---|---|---|---|---|
| First use of STC-1010 immunotherapy with standard chemotherapy for unresectable locally advanced or metastatic colorectal cancer | Phase 1/2 | Baltimore, Maryland and 8 other locations | Recruiting | Apr 18, 2025 |
| Bevacizumab Dose Tuning in First-Line Metastatic Colorectal Cancer Based on Blood Levels | Phase 3 | Besançon and 3 other locations | Recruiting | Oct 15, 2024 |
| Treatment for advanced colorectal cancer using CYAD-101 and pembrolizumab | Phase 1 | Jacksonville, Florida and 4 other locations | Recruiting | Aug 5, 2021 |
| Combination of chemotherapy and immunotherapy for advanced colorectal cancer | Phase 1 | Tampa, Florida and 3 other locations | Recruiting | Oct 2, 2018 |
All recruiting trials (4)
-
First use of STC-1010 immunotherapy with standard chemotherapy for unresectable locally advanced or metastatic colorectal cancer
This trial will test whether adding a new immunotherapy called STC-1010 plus immune stimulants to standard chemotherapy helps people with unresectable locally advanced or metastatic colorectal cancer.
-
Bevacizumab Dose Tuning in First-Line Metastatic Colorectal Cancer Based on Blood Levels
This trial tests whether doubling the bevacizumab dose in patients with low initial bevacizumab blood levels improves outcomes in first-line unresectable metastatic colorectal cancer.
-
Treatment for advanced colorectal cancer using CYAD-101 and pembrolizumab
This study is testing a new treatment combining CYAD-101 with chemotherapy and pembrolizumab to see if it helps people with advanced colorectal cancer who haven't had success with other treatments.
-
Combination of chemotherapy and immunotherapy for advanced colorectal cancer
This study is testing if a new immune therapy combined with standard chemotherapy can help people with advanced colorectal cancer feel better and improve their treatment outcomes.
Related topics
Quick answers
How many Unresectable Metastatic Colorectal Cancer clinical trials are recruiting right now?
4, as of November 12, 2026. We update this list each time we refresh our data from ClinicalTrials.gov.
Where are these trials running?
In 3 countries. The most sites are in Belgium (3 trials), United States (3 trials), France (2 trials). Each study page lists its sites and which ones are recruiting.
What phases are they in?
Phase 1: 2, Phase 1/2: 1, Phase 3: 1. Trials with no phase listed are usually device, behavioural or observational studies.
How do I join one?
Open a study, check the "Is this trial a fit for you?" section, then contact the study team listed on the page. They will ask a few screening questions. Asking is free and does not commit you to anything. Talk it over with your doctor first.
Find the studies that fit you
A list is a starting point. Tell us your situation in your own words and we'll rank the studies that match and explain why. It's free and needs no account.